|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
18,540,000 |
Market
Cap: |
153.51(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$7.27 - $33.01 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Co.'s proprietary platform technology, BAROSTIM®, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System (ANS) which causes heart failure (HF) and other cardiovascular diseases. Co.'s second-generation product, BAROSTIM NEO®, is the first and only commercially available neuromodulation device indicated to improve symptoms for patients with HF and resistant hypertension.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
36,865 |
Total Buy Value |
$0 |
$0 |
$0 |
$185,794 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
4 |
Total Shares Sold |
2,545 |
6,270 |
8,020 |
12,620 |
Total Sell Value |
$55,748 |
$151,890 |
$183,171 |
$238,102 |
Total People Sold |
1 |
2 |
2 |
2 |
Total Sell Transactions |
1 |
2 |
4 |
5 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sandell Scott D |
10% Owner |
|
2021-07-02 |
4 |
B |
$18.00 |
$4,504,500 |
I/I |
250,250 |
173,388 |
1.5 |
-27% |
|
Sandell Scott D |
10% Owner |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,947,837 |
148,638 |
|
- |
|
Glaxosmithkline Plc |
10% Owner |
|
2021-07-02 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
1,007,583 |
1.5 |
-27% |
|
Glaxosmithkline Plc |
10% Owner |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
700,772 |
732,583 |
|
- |
|
Johnson & Johnson Development Corp Et Al |
10% Owner |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,495,575 |
3,495,575 |
|
- |
|
Slattery Joseph P |
Director |
|
2021-07-02 |
4 |
A |
$18.00 |
$99,990 |
D/D |
5,555 |
5,555 |
|
- |
|
Nehra John M |
Director |
|
2021-07-02 |
4 |
B |
$18.00 |
$499,986 |
D/D |
27,777 |
28,266 |
2.39 |
-27% |
|
Jain Mudit K. |
Director |
|
2021-07-02 |
4 |
B |
$18.00 |
$3,999,996 |
I/I |
222,222 |
933,383 |
2.1 |
-27% |
|
Jain Mudit K. |
Director |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
711,161 |
711,161 |
|
- |
|
Brintnall John |
Chief Strategy Officer and Sec |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,900 |
7,900 |
|
- |
|
Nielsen Kirk G. |
Director |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,461,831 |
1,461,831 |
|
- |
|
Pardo Geoffrey B |
Director |
|
2021-07-02 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
1,829,022 |
2.1 |
-27% |
|
Pardo Geoffrey B |
Director |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,554,022 |
1,554,022 |
|
- |
|
Nehra John M |
Director |
|
2021-07-01 |
4 |
B |
$25.80 |
$1,290 |
I/I |
50 |
100 |
2.02 |
-29% |
|
Jain Mudit K. |
Director |
|
2021-07-01 |
4 |
B |
$25.10 |
$25,100 |
D/D |
1,000 |
1,000 |
2.39 |
-29% |
|
Nehra John M |
Director |
|
2021-06-30 |
4 |
B |
$27.43 |
$1,371 |
I/I |
50 |
50 |
2.02 |
- |
|
66 Records found
|
|
Page 3 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|